CSIMarket
 


Encompass Health Corporation  (EHC)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare


Encompass Health's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Encompass Health's ROI in the fourth quarter of 2023?
Encompass Health Corporation achieved a return on average invested assets (ROI) of 9.25 % in its fourth quarter of 2023, which is below Encompass Health's average return on investment, which stands at 18.88%.

ROI fell compared to the third quarter of 2023, despite the net income growth of 5.03% from the third quarter of 2023.

Within the Healthcare sector 55 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2023 quarter, so far to 536, from total ROI ranking in the third quarter of 2023 at 874.

Definition and Formula of Return on Investment


Return On Investment (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Investment Change 8.06 % 9.04 % -17.21 % -17.36 % -
Y / Y Net Income Change 1.36 % 69.25 % 64.38 % 2.91 % 1.56 %
Investment (TTM) in Millions 5,163 5,061 4,930 4,869 4,778
Return On Investment (TTM) 9.25 % 9.4 % 8.64 % 7.29 % 6.88 %
EHC's Overall Ranking # 536 # 874 # 991 # 329 # 503
Seq. Investment Change 2.02 % 2.64 % 1.26 % 1.91 % 2.95 %
Seq. Net Income Change 5.03 % -3.24 % 3.44 % -3.57 % 75.37 %
Net Income (TTM) in Millions 463 461 415 369 366




Return On Investment EHC's Ranking
Within: No.
Industry # 4
Sector # 56
Overall # 536

Return On Investment Statistics
High Average Low
71.74 %
18.88 %
6.13 %
(Dec. 30, 2013)   (Sep 30 2020)







Financial Statements
Encompass Health's IV. Quarter Investments $ 5,163 Millions EHC's Balance sheet
Encompass Health's IV. Quarter Income $ 119 Millions Quarterly EHC's Income Statement
EHC's Income by Division See EHC's Income by Division


EHC Annual Return On Investment (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Investments in Millions 5,163 4,778 5,816 5,467 5,116
Y / Y Investment Growth 8.06 % -17.85 % 6.39 % 6.87 % 13.62 %
Net Income in Millions 463 366 517 369 446
Y / Y Net Income Growth 26.54 % -29.25 % 40.24 % -17.27 % 18.75 %
Annual Return On Investment 8.97 % 7.66 % 8.89 % 6.75 % 8.71 %


Annual Roi Comment
In the fiscal year 2023 ROI improved to 8.97 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EHC's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for EHC's Competitors
Roi for Encompass Health's Suppliers
Return On Investment for EHC's Customers

Other Ratios
EHC's Roa EHC's Inventory Turnover Ratio EHC's Growth Rates EHC's Dividend Statistics
EHC's Profitability Ratios EHC's Asset Turnover Ratio EHC's Dividend Growth
EHC's Roe EHC's Valuation Ratios EHC's Financial Strength Ratios EHC's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI
Inmode Ltd   25.09 %
Corcept Therapeutics Inc  21.53 %
Escalon Medical Corp   20.64 %
Vertex Pharmaceuticals Inc  20.61 %
Chemed Corporation  20.26 %
Novartis Ag  20.19 %
Harmony Biosciences Holdings inc   19.75 %
Catalyst Pharmaceuticals Inc   19.15 %
Zoetis Inc   18.93 %
West Pharmaceutical Services Inc   18.65 %
Protalix Biotherapeutics inc   18.12 %
Edwards Lifesciences Corporation  17.49 %
Exelixis Inc   17.29 %
Halozyme Therapeutics Inc   16.81 %
Astrazeneca Plc  16.41 %
United Therapeutics Corporation  15.77 %
Eli Lilly And Company  15.18 %
Alpha Pro Tech Ltd   15.16 %
Regeneron Pharmaceuticals Inc   14.46 %
Resmed Inc   14.24 %
Intuitive Surgical Inc   14.18 %
Shockwave Medical Inc   13.81 %
Utah Medical Products Inc  13.61 %
Ufp Technologies Inc   13.08 %
Orasure Technologies Inc  12.68 %
Progyny Inc   12.20 %
Pro dex Inc   12.04 %
Dexcom Inc   12.01 %
Organon and Co   11.96 %
Cadre Holdings Inc   11.72 %


Date modified: 2024-02-29T19:05:01+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com